iRadimed (NASDAQ:IRMD) is a medical devices company that sells two primary products: MRI-compatible intravenous (IV) infusion pumps and MRI scanners. The pumps account for the vast majority (79%) of total revenue, with IV sets and services utilized in the pumps accounting for 20% of revenue. The company’s MRI-compatible vital signs monitoring system (3880 Monitors) are a fairly new product that the company only began marketing in 2016, hence revenue is expected to grow quickly despite starting from a small base.
